Novartis Investigative Site

Stadtroda 07646

1 studies enrolling now · 6 studies all time

What they study most

Anti-Dyskinesia Agents, Dyskinesia, Drug-Induced, Dyskinesias, Levodopa, Movement Disorders, Parkinson Disease, Parkinsonian Disorders, Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS), Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy — Recruiting now
• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed
• Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — Completed
• Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — Completed
• Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — Completed
• Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — Completed